VCM
JUNO

Versant Capital Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Versant Capital Management’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15
Closed – – 1767
2017
Q4 		$0 Hold
15
– – ﹤0.01% 1726
2017
Q3 		$0 Hold
15
– – ﹤0.01% 1657
2017
Q2 		$0 Hold
15
– – ﹤0.01% 1627
2017
Q1 		$0 Buy
+15
New +$322 ﹤0.01% 1618

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Versant Capital Management's JUNO Position: Q1 2018 in Review

Versant Capital Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 15 shares.

Versant Capital Management first reported a position in JUNO in Q1 2017 and held it in 4 quarters. The position peaked at $0 in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Versant Capital Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Versant Capital Management sold 15 Juno Therapeutics, Inc. shares in Q1 2018.
  • Versant Capital Management first reported a position in Juno Therapeutics, Inc. in Q1 2017 and held it in 4 quarters.
  • Versant Capital Management's Juno Therapeutics, Inc. position peaked at $0 in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Versant Capital Management's 13F filing for Q1 2018, filed 19 Apr 2018.